Stress as a cause of chronic recurrent vulvovaginal candidosis and the effectiveness of the conventional antimycotic therapy

Mycoses

Volumn 49, Issue 3, 2006, Pages 202-209

  Meyer, Harald ^a   Goettlicher, Sigurd ^b   Mendling, Werner ^c  

^a UNIVERSITY OF BAMBERG   (Germany)

^b Practice of Obstetrics and Gynecology   (Germany)

^c VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

Author keywords

Risk factors; Stress; Therapy; Vulvovaginal candidosis

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CANDIDA ALBICANS; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GOTTLICHER MEYER HYPOTHESIS; HEALTH MAINTENANCE ORGANIZATION; HUMAN; HYPOTHESIS; IMMUNITY; MAJOR CLINICAL STUDY; POISSON DISTRIBUTION; PREDICTION; PRIORITY JOURNAL; PSYCHOSOCIAL DEVELOPMENT; PSYCHOSOMATICS; RECURRENT INFECTION; RELAPSE; RISK FACTOR; STRESS; SYMPTOMATOLOGY; VAGINA CANDIDIASIS;

ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; CHRONIC DISEASE; FEMALE; HUMANS; RECURRENCE; RISK FACTORS; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

CANDIDA; CANDIDA ALBICANS;

EID: 33646258746     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01235.x     Document Type: Article

References (16)

1. Göttlicher S Meyer H. Vulvovaginalmykose. Klinische Ergebnisse einer epidemiologischen Langzeitstudie Stuttgart, New York Thieme 1998
2. Meyer H Göttlicher S. Psycho-social risk factors in vulvovaginal mycosis. A multivariate logit-analysis Mycoses 1998 41 Suppl. 2 49 53
3. Schedlowsky M Tewes U. eds Psychoneuroimmunologie Heidelberg, Berlin, Oxford Spektrum Akademischer Verlag 1993
4. Mendling W Seebacher C. Guideline vulvovaginal candidosis: Guideline of the German Dermatologic Society, the German Speaking Dermatologic Society and the working Group for Infections and Infectimmunology in Gynecology and Obstetrics of the German Society of Gyneacology and Obstetrics Mycoses 2003 46 365 9
5. Tietz HJ Mendling W. Haut-und Vaginalmykosen Berlin, Wien Blackwell Wissenschafts-Verlag 2001
6. Folkman S Lazarus RS. Ways of Coping Questionnaire Palo Alto, CA Consulting Psychologists Press 1998
7. Lazarus RS Folkman S. Stress, Appraisal and Coping New York Springer 1984
8. Lazarus RS Folkman S. Coping as a mediator of emotion J Pers Soc Psychol 1988 54 466 75
9. König H. Streß und Vulvovaginalmykose-Eine empirische Studie zur Bedeutung von Distress bei der Erstmanifestation und Rezidive vulvovaginaler Candidamykosen Bamberg, Germany Institute of Theoretical Psychology, Otto-Friedrich-Universität Bamberg 2000
10. Fisz M. Wahrscheinlichkeitsrechnung und Mathematische Statistik Berlin VEB Deutscher Verlang der Wissenschaften 1971
11. Patel DA Gillespie B Sobel JD et al. Risk factors for recurrent vulvovaginal candidosis in women receiving maintainance antifugal therapy: results of a prospective cohort study Amer J Obstet Gynecol 2004 190 644 53
12. Mendling W Krauss C Fladung B. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten® two formats) with oral single dose fluconazole (Diflucan®) in vulvovaginal mycoses Mycoses 2004 47 136
13. Mendling W Koldowsky U. Immunological findings in patients with cronically recurrent vaginal candidosis and new therapeutical approaches Mycoses 1989 32 386 90
14. Mendling W Koldowsky U. Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses Inf Dis Obstet Gynecol 1996 4 225 31
15. Witkin SS Giraldo PC Linhares J. New insights into the immune pathogenesis of recurrent vulvovaginal candidosis Il J Gyneacol Obstet 2000 3 114 8
16. Fidel PL Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidosis Clin Microbiol Rev 1996 9 335 48